A Study of Zavegepant Given Through The Nose Compared With Placebo in Hospitalized Adults With COVID-19 Who Needed Supplemental Oxygen
Phase 2/3: Double-Blind, Randomized, Placebo Controlled, Safety, and Efficacy Trial of Zavegepant (BHV-3500) Intranasal (IN) for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen
Category & Conditions: Coronavirus Disease (COVID-19)
Medicine: ZAVZPRET™(ZAVEGEPANT)
ClinicalTrials.gov Identifier (NCT): NCT04346615
Protocol ID: C5301004
Open Plain Language Summary Result:
Click here